Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.gov public full text Public Domain

Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets

Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · 2003
ClinicalTrials.gov · Datasets · License: Public Domain · 2003
Open Source ↗
diabetes-mellitusdyslipidemiatype-2
European physicians tend to always use the lowest dose of statins to initiate therapy even in subjects who require large reductions in cholesterol. The study evaluates if selecting the starting dose based on baseline and target LDL-C cholesterol would provide better results (ie proportion of subjects resching target)
Conceptio Open Archive

Analyze & explore related research in Conceptio

Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.

This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 836012
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive